MB Venture Partners
Private Equity for the Life Sciences
2007
10/09/07 - Spinal Restoration Closes $16M Series B Financing
08/09/07 - KFx Medical Closes $10M Series B Financing
04/11/07 - Applied Spine Closes $28 Million C
02/13/07 - Cayenne Medical Closes $12.7 Million Series B
2006
09/25/06 - MB Venture Partners adds Mike Sherman as Executive in Residence
06/08/06 - Protein Discovery and Bruker Daltonics Announce Collaboration
06/07/06 - BioMimetic Grafting Material Receives Canadian Approval
05-12-06 - BioMimetic Therapeutics Completes Initial Public Offering
05/11/06 - AxioMed Appoints Patrick McBrayer as President and CEO
04/25/06 - Alveolus Closes $15 Million Series C Financing
03/20/06 - BioMimetic Pharmaceuticals Initiates Clinical Trials With Novel Bio-Active Drug-Device Combination Product for Orthopedic Indications
1-17-06 - Protein Discovery Recruits Mike Story to Scientific Advisory Board
2005
12-01-05 - BioSet Adds Brent Atkinson, PhD as VP Product Development
11/21/05 - BioMimetic Receives FDA Approval
10-12-05 - BioMimetic Therapeutics Names Larry Papasan Chairman of the Board
09-20-05 - Kereos, Inc. Secures $19.5 Million in Series B Financing
08-24-05 - KFx Corporation Closes $6.2 Million Series A Financing
07-15-05 - BioMimetic Strengthens Management Team with Steven Hirsch as VP, Orthopedics
03-04-05 - Alveolus Implants First Aero Tracheobronchial Stent in UK
02-21-05 - AxioMed Spine Corporation Receives $18 Million in Series B Financing
02-01-05 - GTx, Inc. Initiates Phase I Clinical Trial for its Second SARM, Ostarine
01-26-05 - GTx, Inc. Initiates Pivotal Phase III Clinical Trial for the Prevention of Prostate Cancer in High Risk Men
2004
12-14-04 - GTx Acquires Exclusive Rights in the U.S. for Toremifene
11-04-04 - BioMimetic Completes $25.7 Million Series C Financing
10-07-04 - GTx, Inc. Appoints Timothy R.G. Sear to Board of Directors
08-27-04 - TriVirix Ranked #1 Fast-Growing Company in Deloitte's Technology Fast 50
08-05-04 - BioSet Raises $5 million in Series B Financing
07-30-04 - Alveolus Receives $10 Million in VC Funding
07-16-04 - GTx, Inc. to Present New Phase IIb Clinical Trial Data for ACAPODENE™ at the Fourth International Prostate Cancer Congress
07-15-04 - BioMimetic Pharmaceuticals Receives Approvaable Recommendation from FDA Advisory Panel for GEM 21S
06-02-04 - GTx, Inc, Announces Positive Phase IIb Data for Acapodene
05-05-04 - BioMimetics Pharmaceuticals' PMA for GEM21S Accepted for Review by the Food and Drug Administration
03-17-04 - GTx Enters into a Worldwide Collaboration, License and Co-promotion Agreement with Ortho Biotech Products, L.P., for Andarine, a Selective Androgen Receptor Modulator (SARM)
03-15-04 - AxioMed Spine Corporation Names David K. Floyd President and CEO
02/12/04 - BioMimetic Pharmaceuticals Announces Additions to Senior Management Team
02/03/04 - GTx, Inc. Announces Initial Public Stock Offering
1/08/04 - BioMimetic Pharmaceuticals and Luitpold Pharmaceuticals Establish Strategic Alliance
2002-2003
12/09/03 - QGENICS BIOSCIENCES, INC. Appoints Dr. Richard M. Caprioli to its Scientific Advisory Board
9/30/03 - QGENICS BIOSCIENCES, INC. Awarded Two Phase I Small Business Innovative Research (SBIR) Grants from the National Institutes of Health
08/21/03 - AxioMed Spine Corporation Receives Additional $500,000. First Round of Investment Totals $3.25 Million with Addition of MB Venture Partners LLC
08/20/03 - GTx Announces Closing of Series E Financing
07/30/03 - QGENICS BIOSCIENCES, INC. Awarded Phase I Small Business Innovative Research (SBIR) Grant
06/23/03 - GTX, INC. Presents Pre-Clinical Data on its SARMS Program at the 85th Annual Meeting of the Endocrine Society
06/03/03 - QGENICS Biosciences Announces the Addition of Dean G. Hafeman as Vice President of Research and Development
05/21/03- BioMimetic Pharmaceuticals Closes Series B Venture Funding
05/15/03-QGENICS Biosciences Appoints Seven Members to its Scientific Advisory Board
04/11/03-MB Venture Partners hires Ph.D to guide biotech investments
01/15/03- QGENICS Biosciences Raises $1.0 Million in Series A Financing
10/11/02- MB Venture Partners launches crusade for biotech investment
NEWS ARCHIVE
